Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Biliopancreatic malignancy: future prospects for progress.

J J Ho1, Y S Kim

  • 1Gastrointestinal Research Laboratory (151 M2), Veterans Medical Center, San Francisco, California, USA.

Annals of Oncology : Official Journal of the European Society for Medical Oncology
|August 7, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Incidence of percutaneous injury in Taiwan healthcare workers.

Epidemiology and infection·2015
Same author

Influence of a targeted educational intervention on evidence-based practice in two Malaysian maternity units: the SEA ORCHID project in Malaysia.

The Medical journal of Malaysia·2012
Same author

Switching transient analysis of a metal/ferroelectric/semiconductor switch diode with high speed response to infrared light.

IEEE transactions on ultrasonics, ferroelectrics, and frequency control·2008
Same author

Emotional disorders among medical students in a Malaysian private medical school.

Singapore medical journal·2007
Same author

Magnesium sulfate for persistent pulmonary hypertension of the newborn.

The Cochrane database of systematic reviews·2007
Same author

Loss of human leucocyte antigen class I and gain of class II expression are early events in carcinogenesis: clues from a study of Barrett's oesophagus.

Journal of clinical pathology·2006
Same journal

The ethical obligation to use positive trial results.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same journal

Lorlatinib: The Crown Jewel of ALK Inhibitors.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same journal

TROP2-Directed Antibody Drug Conjugates: New First-Line Treatment for All Patients with Advanced Triple-Negative Breast Cancer?

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same journal

When artificial intelligence learns to abstain: towards clinically responsible diagnostic support in liver pathology.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same journal

PRMT5 inhibitors in MTAP loss NSCLC with actionable genomic alterations: a new kid on the block?

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same journal

Refining decision making in hormone receptor-positive early-stage breast cancer: moving from static to dynamic.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
See all related articles

Novel pancreatic cancer therapies target growth factors, signaling proteins, and mucins. Strategies include gene therapy, targeted drugs, and vaccines to inhibit tumor growth and metastasis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Pancreatic tumors frequently overexpress growth factors and receptors, driving tumor cell proliferation and angiogenesis.
  • Mutations in key regulatory molecules like ras protein and tumor suppressor p53 promote uncontrolled cell growth.
  • Altered mucin expression in tumors contributes to immunosuppression and facilitates metastasis.

Purpose of the Study:

  • To review novel therapeutic strategies targeting molecular pathways in pancreatic cancer.
  • To highlight emerging treatments aimed at inhibiting tumor growth, proliferation, and metastasis.

Main Methods:

  • Investigating therapies such as ribozymes and antisense nucleic acids to inhibit protein synthesis.
  • Exploring monoclonal antibodies to block growth factor receptor-ligand interactions.

Related Experiment Videos

  • Examining novel drugs targeting tyrosine phosphorylation and farnesylation pathways.
  • Assessing gene therapy approaches for correcting tumor suppressor gene defects.
  • Evaluating tumor antigen vaccines for controlling primary and metastatic disease.

    • Main Results:

    • Emerging therapies show promise in targeting critical molecular drivers of pancreatic cancer.
    • Strategies are being developed to counteract immunosuppression and prevent metastasis.
    • Gene therapy and vaccine-based approaches offer new avenues for treatment.

    Conclusions:

    • Novel therapeutic strategies are under investigation for pancreatic cancer, targeting key molecular pathways.
    • These approaches aim to inhibit tumor growth, angiogenesis, and metastasis.
    • Future treatments may involve a combination of targeted therapies, gene therapy, and immunotherapy.